Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Cumberland Pharmaceuticals	CPIX	30. jan 2025	2.25	+0.45
Cummins	CMI	30. jan 2025	359.68	+1.60
Cumulus Media A	CMLS	30. jan 2025	0.87	-4.41
Curbline Properties	CURB	30. jan 2025	24.75	+0.69
Curevac N.V.	CVAC	30. jan 2025	3.82	-1.29
CuriosityStream	CURI	30. jan 2025	2.18	+1.87
Curis	CRIS	30. jan 2025	3.29	+2.17
CURRENC Group	CURR	30. jan 2025	1.60	-6.43
Curtiss-Wright	CW	30. jan 2025	346.84	+2.49
Cushing Mlp & Infrastructure Total Return Fund	SRV	30. jan 2025	45.84	+1.64
Cushman & Wakefield	CWK	30. jan 2025	13.87	+1.99
Custom Truck One Source	CTOS	30. jan 2025	5.29	+1.93
Customers Bancorp	CUBI	30. jan 2025	57.31	+0.17
Customers Bancorp E Pref	CUBI-E	30. jan 2025	25.93	+0.86
Customers Bancorp F Pref	CUBI-F	30. jan 2025	25.51	0.00
Cutera	CUTR	30. jan 2025	0.41	-0.22
CVB Financial	CVBF	30. jan 2025	21.06	+1.30
CVD Equipment	CVV	30. jan 2025	3.45	-0.86
CVR Energy	CVI	30. jan 2025	19.07	-3.05
Cvr Partners LP Unit	UAN	30. jan 2025	82.42	+0.05
CVRx	CVRX	30. jan 2025	16.81	-0.24
CVS Health	CVS	30. jan 2025	56.82	-0.14
CXApp A	CXAI	30. jan 2025	1.53	0.00
CyberArk Software	CYBR	30. jan 2025	371.63	+0.84
Cybin	CYBN	30. jan 2025	9.98	+1.22
Cyclacel Pharmaceuticals	CYCC	30. jan 2025	0.36	+0.62
Cyclacel Pharmaceuticals Pref	CYCCP	30. jan 2025	7.40	-8.64
Cyclerion Therapeutics	CYCN	30. jan 2025	2.54	+7.17
Cyclo Therapeutics	CYTH	30. jan 2025	0.70	-9.44
Cyngn	CYN	30. jan 2025	0.33	-10.28

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.